| MeSH term | MeSH ID | Detail |
|---|---|---|
| Graves Ophthalmopathy | D049970 | 3 associated lipids |
| Leukemia, B-Cell | D015448 | 3 associated lipids |
| Goiter | D006042 | 4 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Lymphoma, T-Cell | D016399 | 11 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Fibrosis | D005355 | 23 associated lipids |
| Lymphoma, B-Cell | D016393 | 24 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Liver Cirrhosis, Experimental | D008106 | 36 associated lipids |
15-deoxy-delta-12,14-PGJ2
15-deoxy-delta-12,14-pgj2 is a lipid of Fatty Acyls (FA) class. 15-deoxy-delta-12,14-pgj2 is associated with abnormalities such as Dehydration and Myocardial Ischemia. The involved functions are known as Binding (Molecular Function), Inflammation, Alveolar ventilation function, Stimulus and Process. 15-deoxy-delta-12,14-pgj2 often locates in Cytosol, Myocardial tissue and Heart tissue. The associated genes with 15-deoxy-delta-12,14-PGJ2 are Homologous Gene and G-substrate. The related lipids are 15-deoxyprostaglandin J2 and Lipopolysaccharides.
Cross Reference
Introduction
To understand associated biological information of 15-deoxy-delta-12,14-PGJ2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 15-deoxy-delta-12,14-PGJ2?
15-deoxy-delta-12,14-PGJ2 is suspected in Dehydration, Myocardial Ischemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 15-deoxy-delta-12,14-PGJ2
PubChem Associated disorders and diseases
What pathways are associated with 15-deoxy-delta-12,14-PGJ2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 15-deoxy-delta-12,14-PGJ2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 15-deoxy-delta-12,14-PGJ2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 15-deoxy-delta-12,14-PGJ2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen CW et al. | Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. | 2003 | J. Immunol. | pmid:12847270 |
| Laurora S et al. | Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. | 2003 | J. Pharmacol. Exp. Ther. | pmid:12649303 |
| Kim BE et al. | Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. | 2003 | Exp. Mol. Med. | pmid:14508070 |
| Fukuchi K et al. | Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. | 2003 | J. Dent. Res. | pmid:14514760 |
| Cuzzocrea S et al. | Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. | 2003 | Br. J. Pharmacol. | pmid:12970094 |
| Powell WS | 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? | 2003 | J. Clin. Invest. | pmid:12975467 |
| Bell-Parikh LC et al. | Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. | 2003 | J. Clin. Invest. | pmid:12975479 |
| Kanbe E et al. | DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand. | 2003 | Exp. Hematol. | pmid:12691917 |
| Zernecke A et al. | Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. | 2003 | FASEB J. | pmid:12692090 |
| Castaño E and Gil J | 15-deoxy-delta12,14 prostaglandin J2 synergizes with phorbol ester to induce proliferation in Swiss 3T3 cells independently of peroxisome proliferator-activated receptor gamma and PGD2 receptors. | 2003 | J. Cell. Physiol. | pmid:12704651 |
| Oliva JL et al. | The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras. | 2003 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12684535 |
| Moore RM et al. | Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. | 2003 Feb-Mar | Placenta | pmid:12566244 |
| Dong YG et al. | Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells. | 2004 | Acta Pharmacol. Sin. | pmid:14704122 |
| Kumar AP et al. | Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. | 2004 | J. Biol. Chem. | pmid:14668325 |
| Itoh K et al. | Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). | 2004 | Mol. Cell. Biol. | pmid:14673141 |
| Kasim-Karakas SE et al. | Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. | 2004 | J. Clin. Endocrinol. Metab. | pmid:14764771 |
| Matsuo T et al. | 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB. | 2004 | Biochem. Biophys. Res. Commun. | pmid:14741709 |
| Downie MM et al. | Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. | 2004 | Br. J. Dermatol. | pmid:15491415 |
| Józkowicz A et al. | Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. | 2004 | Biochem. Biophys. Res. Commun. | pmid:14715242 |
| Ward JE et al. | PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. | 2004 | Br. J. Pharmacol. | pmid:14718259 |
| Ray DM et al. | Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. | 2004 | Clin. Immunol. | pmid:15451478 |
| Abdelrahman M et al. | The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. | 2004 | Shock | pmid:15545828 |
| Inoue K et al. | Effects of 15-deoxy-delta12,14-prostaglandin J2 on the cyclooxygenase-2 expression in the murine lung in the presence of lipopolysaccharide. | 2004 | Arzneimittelforschung | pmid:15612612 |
| Chen Q et al. | A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. | 2004 | Anal. Biochem. | pmid:15556564 |
| Józkowicz A et al. | 15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15560113 |
| Kumagai M et al. | 15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. | 2004 | Tohoku J. Exp. Med. | pmid:14998300 |
| Emi M and Maeyama K | The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. | 2004 | Biochem. Pharmacol. | pmid:15013841 |
| Azuma Y et al. | Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1. | 2004 | J. Pharmacol. Sci. | pmid:15037811 |
| Diab A et al. | Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. | 2004 | J. Neuroimmunol. | pmid:14975592 |
| Paumi CM et al. | Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). | 2004 | Biochemistry | pmid:14979731 |
| Cheng S et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. | 2004 | J. Biol. Chem. | pmid:15023995 |
| Alvarez-Maqueda M et al. | 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. | 2004 | J. Biol. Chem. | pmid:15024026 |
| Hashimoto K et al. | Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. | 2004 | Pancreas | pmid:15028947 |
| Relic B et al. | 15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. | 2004 | J. Biol. Chem. | pmid:15004016 |
| Lupi R et al. | Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. | 2004 | Am. J. Physiol. Endocrinol. Metab. | pmid:14625208 |
| Konopleva M et al. | Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. | 2004 | Mol. Cancer Ther. | pmid:15486192 |
| Ishii T and Uchida K | Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. | 2004 | Chem. Res. Toxicol. | pmid:15487891 |
| Liu JD et al. | Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. | 2004 | Life Sci. | pmid:14998722 |
| Sabichi AL et al. | Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. | 2004 | Cancer Epidemiol. Biomarkers Prev. | pmid:15533896 |
| Subbarayan V et al. | Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. | 2004 | Cancer Epidemiol. Biomarkers Prev. | pmid:15533897 |
| Eucker J et al. | Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. | 2004 | Anticancer Drugs | pmid:15514564 |
| Giri S et al. | The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. | 2004 | J. Immunol. | pmid:15470065 |
| Emmans VC et al. | Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. | 2004 | Biochem. Soc. Trans. | pmid:15494029 |
| Huang H et al. | Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. | 2004 | Mol. Cancer Res. | pmid:15498928 |
| Asami-Miyagishi R et al. | Expression and function of PPARgamma in rat placental development. | 2004 | Biochem. Biophys. Res. Commun. | pmid:14766236 |
| Higashihara H et al. | Hypoxia-reoxygenation enhances interleukin-8 production from U937 human monocytic cells. | 2004 | Redox Rep. | pmid:15720834 |
| Takagi T et al. | A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats. | 2004 | Redox Rep. | pmid:15720836 |
| Mix KS et al. | Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling. | 2004 | Mol. Pharmacol. | pmid:14742672 |
| Yuan Z et al. | Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. | 2004 | J. Cardiovasc. Pharmacol. | pmid:15167281 |
| Lee KJ et al. | Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. | 2004 | Exp. Mol. Med. | pmid:15665586 |
| Cheron A et al. | 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. | 2004 | J. Immunol. | pmid:15187150 |
| Maddox JF et al. | 15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes. | 2004 | Toxicol. Sci. | pmid:14657518 |
| Baek SJ et al. | Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. | 2004 | J. Biol. Chem. | pmid:14662774 |
| Zhang X et al. | Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. | 2004 | Kidney Int. | pmid:14871400 |
| Ueta M et al. | PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose. | 2004 | Kidney Int. | pmid:14871416 |
| Badawi AF et al. | Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. | 2004 | Cancer Res. | pmid:14871855 |
| Levonen AL et al. | Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. | 2004 | Biochem. J. | pmid:14616092 |
| Reddy RC et al. | Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. | 2004 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:14617516 |
| Asada K et al. | Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. | 2004 | Am. J. Respir. Crit. Care Med. | pmid:14563653 |
| Ehara N et al. | Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15358182 |
| Li L et al. | Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. | 2004 | J. Hepatol. | pmid:15336443 |
| Grau R et al. | Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. | 2004 | Cancer Res. | pmid:15289320 |
| Kielian T et al. | S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). | 2004 | J. Neurochem. | pmid:15312171 |
| Weber SM et al. | PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. | 2004 | Am. J. Physiol. Endocrinol. Metab. | pmid:15315910 |
| Siavash H et al. | Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. | 2004 | Br. J. Cancer | pmid:15316561 |
| Sánchez-Gómez FJ et al. | Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. | 2004 | Mol. Pharmacol. | pmid:15317873 |
| Lim SY et al. | 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. | 2004 | J. Biol. Chem. | pmid:15319433 |
| Boyault S et al. | 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. | 2004 | FEBS Lett. | pmid:15304320 |
| Ichiki T et al. | 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15369766 |
| Schlezinger JJ et al. | Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. | 2004 | J. Immunol. | pmid:15322177 |
| Si Q et al. | 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. | 2004 | J. Immunol. | pmid:15322215 |
| Cheng J et al. | Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15325252 |
| Kanunfre CC et al. | Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. | 2004 | Int. Immunopharmacol. | pmid:15251113 |
| Berry EB et al. | Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells. | 2004 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:15253890 |
| Morosetti R et al. | The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. | 2004 | Int. J. Oncol. | pmid:15254749 |
| Hofnagel O et al. | Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. | 2004 | Arterioscler. Thromb. Vasc. Biol. | pmid:15271788 |
| Park KS et al. | Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. | 2004 | Exp. Cell Res. | pmid:15212945 |
| Shan ZZ et al. | A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. | 2004 | J. Biol. Chem. | pmid:15213234 |
| Jawerbaum A et al. | Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. | 2004 | Mol. Hum. Reprod. | pmid:15258247 |
| Zhao ML et al. | 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. | 2004 | J. Neuroimmunol. | pmid:15265671 |
| Zhang X et al. | Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. | 2004 | Blood | pmid:15265789 |
| Azuma Y et al. | Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. | 2004 | Pharmacology | pmid:15240994 |
| Zhang C et al. | The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. | 2004 | J. Invest. Dermatol. | pmid:15245439 |
| Siavash H et al. | Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. | 2004 | Cancer Lett. | pmid:15194221 |
| Ruiz PA et al. | 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. | 2004 | J. Biol. Chem. | pmid:15199053 |
| Shimomura K et al. | Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. | 2004 | J. Pharmacol. Exp. Ther. | pmid:15201343 |
| Cipollone F et al. | Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. | 2004 | Arterioscler. Thromb. Vasc. Biol. | pmid:15155382 |
| Miwa Y et al. | Involvement of clusterin in 15-deoxy-delta12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15158456 |
| Chana RS et al. | Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. | 2004 | Kidney Int. | pmid:15149321 |
| Garg TK and Chang JY | 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. | 2004 | BMC Pharmacol. | pmid:15149553 |
| Park EY et al. | Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. | 2004 | Cancer Res. | pmid:15150131 |
| Akbiyik F et al. | Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. | 2004 | Blood | pmid:15130939 |
| Han S et al. | Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression. | 2004 | Chest | pmid:15136464 |
| Collin M et al. | Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. | 2004 | Crit. Care Med. | pmid:15090969 |
| Zang C et al. | Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. | 2004 | Leuk. Res. | pmid:15109539 |
| Verrier E et al. | PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. | 2004 | Circ. Res. | pmid:15117825 |
| Leung WK et al. | Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. | 2004 | Gut | pmid:14960510 |
| Mouihate A et al. | A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. | 2004 | J. Neurosci. | pmid:14960602 |
| Chatterjee PK et al. | The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. | 2004 | Cardiovasc. Res. | pmid:14962493 |
| Brummond KM et al. | The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. | 2004 | Org. Lett. | pmid:14723515 |